Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 P307 | DOI: 10.1530/endoabs.90.P307

ECE2023 Poster Presentations Calcium and Bone (83 abstracts)

FGF-23 levels in patients with normocalcemic primary hyperparathyroidism

Elena Chertok Shacham 1 , Nimra Maman 2 , Tatyana Lazareva 3 & Avraham Ishay 1


1Emek Medical Center, Endocrinology, Afula, Israel; 2Emek Medical Center, Statistics, Afula, Israel; 3Emek Medical Center, Internal Medicine Department, Afula, Israel


Introduction: Normocalcemic primary hyperparathyroidism (NPHPT) is a variant of primary hyperparathyroidism with consistently normal albumin-adjusted or free-ionized calcium levels. It may be an early stage of classic primary hyperparathyroidism or could represent a primary renal or bone disorder or result from another pathophysiologic mechanism leading to invariably elevated PTH levels.

Aim of the study: The study aims to check and compare the FGF-23 levels in three groups of patients: patients with PHPT, patients with NPHPT, and patients with normal calcium and PTH levels.

Methods: Our study included patients who were referred to the endocrinology clinic with a presumptive diagnosis of primary hyperparathyroidism, an isolated increased level of PTH, or reduced bone densitometry. For each patient, we performed blood analysis of FGF-23, calcium, phosphate, vitamin D [25(OH)D3], estimated glomerular filtration rate (eGFR), bone turnover markers, and urine analysis for calcium/creatinine ratio.

Results: Our study included 105 patients. Thirty patients with hypercalcemic PHPT (HPHPT group), thirty patients with elevated PTH and normal calcium levels (NPHPT group), and 45 patients with normal calcium and PTH levels in the control group. FGF 23 level was 59.5± 23 pg/ml in the NPHPT group, 77±33 pg/ml in the HPHPT group, and 49.7±21.7 pg/ml in the control group (P=0.012). The phosphate level was lowest in the HPHPT group: 2.9 ±0.6 vs 3.5±0.44 in the NPHPT and 3.8±0.5 in the control groups (P=0.001). No differences were found in eGFR, 25(OH)D3, C-terminal telopeptide type I collagen (CTX) and procollagen type 1 N-terminal propeptide (P1NP) levels, and bone densitometry scores between the three study groups. There was a significant positive relationship between PTH and FGF23 levels in two out of three groups of patients (HPHPT and NPHPT groups) when all three groups of patients were analyzed together (P= 0.000). A significant negative correlation was found between the FGF-23 level and GFR in all three study groups (P=0.023).

Conclusion: Our findings suggest that NPHPT is an early stage of PHPT. Further studies are needed to determine the role of FGF-23 and its usefulness in NPHPT.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.